Vectans Pharma is an international company headquarted in France, dedicated to the optimization of existing treatments and the development of innovative products through its Lauriad^® Platform.

With a focus on anti-infective drugs and supportive care, Vectans conceives and develops “Best in disease” treatments.

Created in 2015, Vectans Pharma’s ambition is to become a healthcare leading player by coupling innovation to patient’s needs. The company’s teams have the key competencies required to identify, develop and register drugs in Europe, Asia, North and South America.